Abstract:Alzheimer's disease is characterized by a progressive cognitive decline in older individuals accompanied by the deposition of two pathognomonic proteins amyloid-β and tau. It is well documented that synaptotoxic soluble amyloid-β aggregates facilitate synaptic long-term depression, a major form of synaptic weakening that correlates with cognitive status in Alzheimer's disease. Whether synaptotoxic tau, which is also associated strongly with progressive cognitive decline in patients with Alzheimer's disease and other tauopathies, also causes facilitation remains to be clarified. Young male adult and middle-aged rats were employed. Synaptotoxic tau and amyloid-β were obtained from different sources including (i) aqueous brain extracts from patients with Alzheimer's disease and Pick's disease tauopathy; (ii) the secretomes of induced pluripotent stem cell-derived neurons from individuals with trisomy of chromosome 21; and (iii) synthetic amyloid-β. In vivo electrophysiology was performed in urethane anaesthetized animals. Evoked field excitatory postsynaptic potentials were recorded from the stratum radiatum in the CA1 area of the hippocampus with electrical stimulation to the Schaffer collateral-commissural pathway. To study the enhancement of long-term depression, relatively weak low-frequency electrical stimulation was used to trigger peri-threshold long-term depression. Synaptotoxic forms of tau or amyloid-β were administered intracerebroventricularly. The ability of agents that inhibit the cytokine tumour necrosis factor-α or the integrated stress response to prevent the effects of amyloid-β or tau on long-term depression was assessed after local or systemic injection, respectively. We found that diffusible tau from Alzheimer's disease or Pick's disease patients' brain aqueous extracts or the secretomes of trisomy of chromosome 21 induced pluripotent stem cell-derived neurons, like Alzheimer's disease brain-derived amyloid-β and synthetic oligomeric amyloid-β, potently enhanced synaptic long-term depression in live rats. We further demonstrated that long-term depression facilitation by both tau and amyloid-β was age-dependent, being more potent in middle-aged compared with young animals. Finally, at the cellular level, we provide pharmacological evidence that tumour necrosis factor-α and the integrated stress response are downstream mediators of long-term depression facilitation by both synaptotoxic tau and amyloid-β. Overall, these findings reveal the promotion of an age-dependent synaptic weakening by both synaptotoxic tau and amyloid-β. Pharmacologically targeting shared mechanisms of tau and amyloid-β synaptotoxicity, such as tumour necrosis factor-α or the integrated stress response, provides an attractive strategy to treat early Alzheimer's disease.

Memories of NMDA Receptors and LTP

Mechanisms of Late-Onset Cognitive Decline after Early-Life Stress.

Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress

The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis

Acute restraint stress reverses impaired LTP in the hippocampal CA1 region in mouse models of Alzheimer’s disease

Recovery of Chronic Stress-Triggered Changes of Hippocampal Glutamatergic Transmission

Effect of chronic stress on long-term potentiation of hippocampus and neurotransmitter of amino acid in rats

Stress induced neural reorganization: A conceptual framework linking depression and Alzheimer's disease

Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer’s disease

Synaptic plasticity in depression: molecular, cellular and functional correlates

Antidepressant-like Effects and Possible Mechanisms of Amantadine on Cognitive and Synaptic Deficits in a Rat Model of Chronic Stress

Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis

Corticosteroid Effects on Glutamatergic Transmission and Fear Memory

The Effect of Acute Stress on LTP and LTD Induction in the Hippocampal CA1 Region of Anesthetized Rats at Three Different Ages

Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease

Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer’s Disease

The NMDA receptor as a target for cognitive enhancement

Microglia Activation Regulates Glur1 Phosphorylation in Chronic Unpredictable Stress-Induced Cognitive Dysfunction

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer's disease

Chronic Stress Reduces Nectin-1 Mrna Levels and Disrupts Dendritic Spine Plasticity in the Adult Mouse Perirhinal Cortex

Patient-derived tau and amyloid-β facilitate long-term depression in vivo: role of tumour necrosis factor-α and the integrated stress response